Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Common Equity (2016 - 2025)

Phibro Animal Health has reported Common Equity over the past 13 years, most recently at $332.4 million for Q4 2025.

  • Quarterly results put Common Equity at $332.4 million for Q4 2025, up 34.67% from a year ago — trailing twelve months through Dec 2025 was $332.4 million (up 34.67% YoY), and the annual figure for FY2025 was $285.7 million, up 11.32%.
  • Common Equity for Q4 2025 was $332.4 million at Phibro Animal Health, up from $311.7 million in the prior quarter.
  • Over the last five years, Common Equity for PAHC hit a ceiling of $332.4 million in Q4 2025 and a floor of $215.9 million in Q1 2021.
  • Median Common Equity over the past 5 years was $266.5 million (2022), compared with a mean of $265.7 million.
  • Biggest five-year swings in Common Equity: fell 9.16% in 2024 and later soared 34.67% in 2025.
  • Phibro Animal Health's Common Equity stood at $239.3 million in 2021, then grew by 12.15% to $268.4 million in 2022, then grew by 0.91% to $270.8 million in 2023, then decreased by 8.86% to $246.8 million in 2024, then skyrocketed by 34.67% to $332.4 million in 2025.
  • The last three reported values for Common Equity were $332.4 million (Q4 2025), $311.7 million (Q3 2025), and $285.7 million (Q2 2025) per Business Quant data.